Assessment of the Effect of Age on Duration of Analgesia From Single-shot Femoral Nerve Blocks

Overview

Cohort study to examine the effect of age on duration of analgesia in patients receiving single-shot femoral nerve block prior to surgery, by postoperative phone follow-up questionnaire.

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Prospective
  • Study Primary Completion Date: June 15, 2021

Detailed Description

The purpose of this study is to find out how differences in age can affect the duration of pain relief from a femoral nerve block. Complete recovery after leg surgery involves healing of tissues at the surgical site, recovery of muscle strength and range-of-motion. Some pain is normally experienced after leg surgery. At the hospital, pain is usually treated with pain medicines, and/or a nerve block procedure. A nerve block involves injecting a local anesthetic beside the nerves to numb the nerves that supply feeling to the knee joint and surrounding tissues. The choice as to whether a participant has a nerve block or not is made by the participant and their surgeon and is not determined by this research study. The study aim is to find out how long a nerve block can relieve postsurgical pain, and whether that duration is affected by the age of the participant.

Clinical Trial Outcome Measures

Primary Measures

  • Duration of analgesia
    • Time Frame: From time of block placement to patient to the reported end of analgesic effect, up to 72 hours
    • Total duration of analgesia from peripheral femoral nerve block

Participating in This Clinical Trial

Inclusion Criteria

  • Adult patients (age >18 years)
  • American Society of Anesthesiology physical status 1—3
  • Having ambulatory surgery, who have received a single-shot femoral nerve block
  • Able to read and understand English
  • Have access to a phone after surgery

Exclusion Criteria

  • Pediatric patients (age <18 years)
  • American Society of Anesthesiology physical status >3
  • Unable to read and understand English
  • Unable to have access to a phone after surgery

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • University of Washington
  • Provider of Information About this Clinical Study
    • Principal Investigator: Vanessa Loland, Professor, School of Medicine – University of Washington
  • Overall Official(s)
    • Vanessa J Loland, MD, Principal Investigator, University of Washington
  • Overall Contact(s)
    • Adam J Claessens, DO, 206-291-7445, claessen@uw.edu

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.